IBDEI1LH ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28304,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,28304,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,28304,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,28305,0)
 ;;=V11.0^^162^1794^50
 ;;^UTILITY(U,$J,358.3,28305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28305,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,28305,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,28305,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,28306,0)
 ;;=V10.83^^162^1794^51
 ;;^UTILITY(U,$J,358.3,28306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28306,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,28306,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,28306,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,28307,0)
 ;;=V15.1^^162^1794^53
 ;;^UTILITY(U,$J,358.3,28307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28307,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,28307,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,28307,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,28308,0)
 ;;=V15.82^^162^1794^57
 ;;^UTILITY(U,$J,358.3,28308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28308,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,28308,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,28308,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,28309,0)
 ;;=V12.01^^162^1794^54
 ;;^UTILITY(U,$J,358.3,28309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28309,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,28309,1,5,0)
 ;;=5^Hx Of TB
 ;;^UTILITY(U,$J,358.3,28309,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,28310,0)
 ;;=V13.01^^162^1794^34
 ;;^UTILITY(U,$J,358.3,28310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28310,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,28310,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,28310,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,28311,0)
 ;;=V12.51^^162^1794^59
 ;;^UTILITY(U,$J,358.3,28311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28311,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,28311,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,28311,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,28312,0)
 ;;=V17.89^^162^1794^17
 ;;^UTILITY(U,$J,358.3,28312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28312,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,28312,1,5,0)
 ;;=5^Family H/O Musculosk Dis
 ;;^UTILITY(U,$J,358.3,28312,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,28313,0)
 ;;=V12.54^^162^1794^56
 ;;^UTILITY(U,$J,358.3,28313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28313,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,28313,1,5,0)
 ;;=5^Hx Of TIA
 ;;^UTILITY(U,$J,358.3,28313,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,28314,0)
 ;;=V12.54^^162^1794^52
 ;;^UTILITY(U,$J,358.3,28314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28314,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,28314,1,5,0)
 ;;=5^Hx Of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,28314,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,28315,0)
 ;;=V15.88^^162^1794^31
 ;;^UTILITY(U,$J,358.3,28315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28315,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,28315,1,5,0)
 ;;=5^Hx Of Falls
 ;;^UTILITY(U,$J,358.3,28315,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,28316,0)
 ;;=V13.59^^162^1794^41
 ;;^UTILITY(U,$J,358.3,28316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28316,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,28316,1,5,0)
 ;;=5^Hx Of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,28316,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,28317,0)
 ;;=V12.04^^162^1794^37
 ;;^UTILITY(U,$J,358.3,28317,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1LH
